An international team of cancer researchers from Denmark, the University of Copenhagen (UCopenhagen), and Germany, the German Cancer Research Center, have used cancer patient data to develop a computer model that can predict the course of disease for prostate cancer (lat. Prostate Carcinoma). The model is currently being implemented at a prostate cancer clinic in Germany. The researchers have also found the enzyme that appears to trigger some of the first mutations in prostate cancer. The team studied the earliest mutational events in prostate cancer to develop a computer model. The researchers collected patient data from close to 300 men who have had their entire cancer genome sequenced to characterise all mutations present in the tumour. Based on the data set, the researchers have developed the computer model which can be used to predict how prostate cancer will develop for a given patient. The computer model is currently being implemented at a clinic in Germany.